Binimetinib (ARRY-162, MEK162) is an orally active, selective MEK1/2 inhibitor (IC50 = 12 nM) with antitumor activity, particularly in metastatic melanoma with BRAF V600E/K mutations. Reagent grade, for research use only.
Usually ships within 24 hours.